(a) In this section, “ACCME” means the Accrediting Council for Continuing Medical Education.
(b) A physician may dispense a topical medication that is approved by the federal Food and Drug Administration for the treatment of hypotichosis without obtaining a dispensing permit or completing the continuing education required under § 12–102(c)(2)(ii) of this article if the physician:
(1) Otherwise complies with the requirements of § 12–102(c)(2)(ii) of this article; and
(2) Has received a special class of written permit from the Board.
(c) The Board may issue a special class of written permit to a physician under subsection (b) of this section if the physician:
(1) Completes 1 hour of continuing medical education per year on the dispensing of topical medications developed by an ACCME–accredited Maryland nonprofit or governmental entity; and
(2) Pays to the Board a $100 permit fee.